Merck, sponsor or financial supporter of Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) (ClinicalTrials.gov number, NCT00092677), Improved Reduction of Outcomes: Vytorin Efficacy International ...
The abrupt termination of Pfizer’s ILLUMINATE study with its cholesterol management drug torcetrapib last December illustrates not only the risks and dilemmas attendant on pharmaceutical development ...
On Saturday, a researcher from the University of California, San Francisco, stood in front of a crowd of doctors at the year's biggest cancer conference and presented stunning results from a ...
If the lyrics of the popular Jim Croce song from the early 1970s were adapted for a clinical trialist anthem, the refrain would likely be You don't tug on Superman's cape You don't spit into the wind ...
UNITY-CLL DSMB conducted a pre-planned futility analysis of progression-free survival, and determined that the study was not futile and should continue as planned No safety concerns identified by the ...
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 ...
The emergence of accreditation bodies will introduce new organizations with important roles to play in learning from lapses in the system to ensure continuous improvement, making it all the more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results